Mubadala Investment Co PJSC, 10% Owner at RECURSION PHARMACEUTICALS, INC. (RXRX), bought 133,644 shares at $7.82 ($1.0M) on 2023-03-02, disclosed to the SEC on 2023-03-03.
Open-market purchase of $1.0M RXRX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.82 | 66,822 | $523K | 50.0% |
| 2 | $7.82 | 66,822 | $523K | 50.0% |
| Total | $7.82 avg | 133,644 | $1.0M | 100% |
| Ticker | Type | Filed | Value | 7d Stock | Filing |
|---|---|---|---|---|---|
| PrivateMidCap Apollo Institutional Private Lending | BUY | 2025-09-11 | $86.5M | — | Filing → |
| PrivateMidCap Apollo Institutional Private Lending | BUY |
| 2025-07-31 |
| $37.4M |
| — |
| Filing → |
| RXRX | BUY | 2023-03-02 | $776K | — | Filing → |
| RXRX | BUY | 2023-03-01 | $6K | — | Filing → |
| RXRX | BUY | 2023-02-28 | $404K | — | Filing → |